Could tiny amounts of LSD help people as they approach the end of their cancer journeys?

That's the question posed by Auckland University researchers, as they recruit for their world-first study.

The 40 participants the team hope to find would take either a low dose of LSD -- or one of three possible placebos over six to seven weeks.

Study lead, Dr Lisa Reynolds says high rates of anxiety, depression, and isolation are common among those with stage four cancer.

She's hopeful their work could help alleviate some of those challenges.